Related Experiment Video
Updated: Jul 14, 2026
Stereoacuity Improvement using Random-Dot Video Games
Published on: January 14, 2020
Short- and long-term effects of an intensive inpatient vision rehabilitation program
Joan A Stelmack1, D'Anna Moran, Deborah Dean
1Blind Rehabilitation Center, Edward E. Hines VA Hospital, Hines, IL 60141, USA. Joan.Stelmack@med.va.gov
Objective:
To assess the effects of a visual rehabilitation program on visually impaired subjects' visual ability and ability to perform activities.
Design:
Prospective observational study.
Setting:
Telephone interviews of respondents in their homes the week before admission to the rehabilitation center and 3 months and 1 year after discharge from the rehabilitation center.
Participants:
A total of 178 consecutive patients from the Hines Blind Rehabilitation Center participated in development of the 48-item Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48). Data were analyzed for 95 who participated in all 3 administrations of the questionnaire.
Intervention:
Comprehensive blind rehabilitation program (mean hospital admission, 40 d).
Main Outcome Measure:
The self-report ratings of patients' difficulty performing 48 activities on the VA LV VFQ-48.
Results:
The increase in visual ability +/- standard deviation of .981+/-.482 logits (equivalent to an 8-line improvement in visual acuity on an Early Treatment of Diabetic Retinopathy Study chart) at 3 months postrehabilitation decreased to .682+/-.485 logits (equivalent to a loss of 2.5 lines of visual acuity on the same chart) 1 year postrehabilitation. The effect sizes measured at 3 months (2.035) and 1 year (1.495) indicate large treatment effects corresponding to statistically significant differences for the increase in visual ability at 3 months and 1 year postrehabilitation (paired 2-tailed t tests, P<.001) relative to pretreatment measures. The difference in visual abilities measured at 3 months and 1 year posttreatment also is statistically significant (P<.001).
Conclusions:
Treatment effects decreased over the 12-month follow-up period. However, the group of patients whose data were analyzed was still statistically and clinically significantly better at their 1-year follow-up than before beginning treatment.